A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT06207305
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06204315
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 87
- Registration Number
- NCT06200181
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06200155
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Radiologic Pathologic Correlation of Imaging to Distinguish True Progression from Pseudoprogression in Brain Malignancies
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06199479
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 64
- Registration Number
- NCT06199466
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT06199492
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT06191978
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-28
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06184321
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT06181656
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath